Diamedix Diagnostica Revenue and Competitors
Estimated Revenue & Valuation
- Diamedix Diagnostica's estimated annual revenue is currently $59.1M per year.
 - Diamedix Diagnostica's estimated revenue per employee is $297,000
 
Employee Data
- Diamedix Diagnostica has 199 Employees.
 - Diamedix Diagnostica grew their employee count by 24% last year.
 
Diamedix Diagnostica's People
| Name | Title | Email/Phone | 
|---|
Diamedix Diagnostica Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation | 
|---|---|---|---|---|---|
#1  | $58.5M | 197 | 8% | N/A | N/A | 
#2  | $20.5M | 76 | 3% | N/A | N/A | 
#3  | $202.5M | 600 | 26% | N/A | N/A | 
#4  | $44.8M | 151 | 5% | N/A | N/A | 
#5  | $34M | 126 | 4% | N/A | N/A | 
#6  | $34.8M | 129 | 5% | N/A | N/A | 
#7  | $42.8M | 144 | 31% | N/A | N/A | 
#8  | $16.2M | 69 | -22% | $29.7M | N/A | 
#9  | $2131.5M | 5639 | 10% | $9.3M | N/A | 
#10  | $56.4M | 190 | 18% | N/A | N/A | 
What Is Diamedix Diagnostica?
Diamedix Diagnostica is a company based out of Romania.
keywords:N/AN/A
Total Funding
199
Number of Employees
$59.1M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Diamedix Diagnostica News
2022-04-20 - STD Diagnostics Market Size, Outlook And Forecast | Abbott ...
Abbott, ADI/American Diagnostica, Agilent Technologies, ... Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX,...
2022-04-17 - Tamaño del mercado global de kits de prueba de herpes ...
Decode Genetics Diadexus Diagnocure Diagnostica Stago/Trinity Biotech Diamedix International Technidyne/Nexus DX Kreatech/Leica Polymedco
2022-04-17 - Ventas del mercado global Diagnóstico POC de atención ...
Diagnostica Stago/Trinity Biotech  Diamedix ... de diagnóstico POC de atención primaria incluyen Abbott, ADI/American Diagnostica,...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding | 
|---|---|---|---|---|
#1  | $34.5M | 241 | 16% | N/A | 
#2  | $54.4M | 246 | 7% | N/A | 
#3  | $73.1M | 246 | 17% | N/A | 
#4  | $107.1M | 519 | 9% | N/A | 
#5  | $100.6M | 555 | N/A | N/A | 
